Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
NASDAQ:HCAT

Health Catalyst Q3 2026 Earnings Date & Estimates

Health Catalyst logo
$1.63 -0.06 (-3.55%)
Closing price 04:00 PM Eastern
Extended Trading
$1.64 +0.01 (+0.31%)
As of 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Health Catalyst is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 5:00 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
5:00 PM ET

What Analysts Expect from Health Catalyst in Q3 2026

Health Catalyst is expected to post earnings of -$0.02 per share on revenue of $55.38 million. In the same quarter a year earlier Health Catalyst reported $0.06 per share on revenue of $76.32 million. Health Catalyst last reported on August 6, 2026, posting $0.04 per share and beating the $0.0299 consensus estimate. Health Catalyst has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.02
Expected Revenue
$55.38 million
Prior-Year EPS
$0.06
Prior-Year Revenue
$76.32 million
Expected EPS Growth
-133.3%
Expected Revenue Growth
-27.4%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.04 (Beat by +$0.0101)
Last Quarter Revenue
$70.49 million
EPS Beat Rate
6 of last 8 quarters

Health Catalyst Q3 2026 Earnings FAQ

Health Catalyst (NASDAQ:HCAT) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Health Catalyst's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Health Catalyst to post earnings of -$0.02 per share for Q3 2026.

The consensus revenue estimate for Health Catalyst is $55.38 million for Q3 2026.

Health Catalyst Earnings Headlines

Health Catalyst, Inc. (NASDAQ:HCAT) Stock Has Average Target Price of $2.15
Nvidia's $550 Trillion Problem
Do not buy another AI stock until you've seen the arithmetic below. Nvidia is worth about $5.5 trillion. Alphabet about $4.1 trillion. Microsoft about $3.8 trillion. So what would it take to repeat Nvidia's run? A 100x gain from here puts Nvidia near $550 trillion. Nothing in history has ever been worth that. Big money in Nvidia has already been made. By the people who bought it years ago. But that does not mean the AI boom is finished. It means the opportunity has moved underneath it... to the layer every AI company has to pay to use.tc pixel
See More Health Catalyst Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Health Catalyst? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Health Catalyst and other key companies, straight to your email.

About Health Catalyst

Health Catalyst (NASDAQ:HCAT) is a healthcare technology company that provides data and analytics solutions to help healthcare organizations improve clinical outcomes, operational efficiency and financial performance. Its customers include hospitals, health systems, medical groups and other healthcare organizations seeking to integrate and analyze data from across their operations.

The company’s offerings are built around its Health Catalyst Data Operating System, a cloud-based platform designed to combine information from electronic health records, financial systems and other sources. Health Catalyst also provides analytics applications, artificial intelligence and machine-learning tools, performance improvement support, and professional services for areas such as quality, cost management, population health and care delivery.

Health Catalyst was founded in 2008 and is headquartered in South Jordan, Utah. The company primarily serves the U.S. healthcare market and has worked with healthcare organizations in other regions. Health Catalyst became a publicly traded company on the Nasdaq in 2019 under the ticker symbol HCAT.

View Health Catalyst Profile